Clinical Trials on Glabellar Crease in New Zealand
Total 2404 results
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedBreast Cancer | brca1 Mutation Carrier | brca2 Mutation CarrierUnited States
-
Takara Bio Inc.CompletedMalignant Melanoma | Carcinoma of the Breast | Squamous Cell Carcinoma, Skin | Refractory Head and Neck CancerUnited States
-
Jazz PharmaceuticalsRecruitingMetastatic HER2-positive Breast CancerUnited States, Austria, Italy, Spain, France, United Kingdom, Japan, Germany, Belgium, Greece, Australia, Canada, Poland, Brazil, South Korea
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedBreast CancerUnited States, Canada, Australia, Ireland
-
Genentech, Inc.Approved for marketing
-
Spectrum Pharmaceuticals, IncCompletedBreast CancerUnited States
-
Hoffmann-La RocheCompletedBreast CancerUnited States, Korea, Republic of, Canada, United Kingdom, Australia, Belgium, Brazil, France, Slovenia, Spain, Taiwan, Japan, Italy, Argentina, India, Germany, Hungary, Russian Federation, Singapore, Ukraine, Costa Rica, Czechia, G... and more
-
AstraZenecaCompletedAdvanced Castrate-resistant Prostate Cancer CRPC | Squamous Non-Small Cell Lung Cancer sqNSCLC | Triple Negative Breast Cancer TNBCSpain, Canada, United States, United Kingdom
-
The University of New South WalesNational Health and Medical Research Council, Australia; Novo Nordisk A/S; Sydney...CompletedType 1 Diabetes | Puberty: >Tanner 2 Breast Development or Testis >4mlAustralia
-
Novartis PharmaceuticalsTranslational Research in OncologyActive, not recruitingEarly Breast CancerUnited States, Canada, Italy, United Kingdom, Austria, Taiwan, Australia, Germany, Belgium, Spain, China, France, Brazil, Argentina, Hungary, Poland, Ireland, Romania, South Korea, Russia
-
National Cancer Institute (NCI)NRG OncologyCompletedStage IB Breast Cancer AJCC v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7 | HER2-Positive Breast Carcinoma | Hormone Receptor-Positive Breast CarcinomaUnited States, Puerto Rico
-
Memorial Sloan Kettering Cancer CenterRecruitingBreast Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Prostate Cancer | Educational Materials for Genetic TestingUnited States
-
Ontario Clinical Oncology Group (OCOG)GenesisCare AURecruitingBreast Neoplasm Female | Radiotherapy | Cosmetic OutcomeCanada, Australia
-
Novartis PharmaceuticalsTerminatedMetastatic Breast CancerSouth Africa, France, Italy, Taiwan, Hungary, Belgium, Spain, Austria, Netherlands, Poland, Russian Federation, United States, Argentina, Brazil, Peru
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedBreast Cancer | Colorectal Cancer | Lung Cancer | Prostate CancerUnited States
-
NovartisApproved for marketingNeoplasms, BreastChina, United States, Spain, United Kingdom, Austria, Belgium, Estonia, Canada, Netherlands, Singapore, Australia, Germany, Israel, Italy, Poland, Russian Federation, Sweden, Switzerland, Taiwan, Thailand, Brazil, Denmark, Ireland, Korea... and more
-
BioNTech SEBristol-Myers SquibbRecruitingBreast NeoplasmsUnited States, Australia, China, Japan, Italy, Spain, United Kingdom, Belgium, Poland, Georgia, South Korea, Czechia, Germany
-
Calithera Biosciences, IncTerminatedClear Cell Renal Cell Carcinoma | Colorectal Cancer | Solid Tumor | CRC | TNBC - Triple-Negative Breast Cancer | ccRCC | RCCUnited States
-
National Cancer Institute (NCI)Active, not recruitingBreast Ductal Carcinoma In Situ | Invasive Breast Carcinoma | Multicentric Breast Carcinoma | Multifocal Breast Carcinoma | Synchronous Bilateral Breast CarcinomaUnited States, France, Spain, Canada, Saudi Arabia, Puerto Rico, Ireland, Mexico, South Korea, Colombia
-
Veru Inc.TerminatedMetastatic Breast CancerUnited States, Spain, Poland, Ukraine
-
Hoffmann-La RocheCompletedMetastatic Breast CancerUnited States, Korea, Republic of, United Kingdom, Italy, Russian Federation, Argentina, Belgium, Brazil, Panama, Germany, Japan, Ukraine, Chile, South Africa, Bulgaria, Romania
-
AbbVieTerminatedCancer | Breast CancerUnited States, Germany, Japan, Puerto Rico
-
National Center for Complementary and Integrative...CompletedCardiovascular Diseases | Breast Cancer | Osteoporosis | Endometrial CancerUnited States
-
Eli Lilly and CompanyApproved for marketingMetastatic Breast CancerSpain, Canada, Australia, Taiwan, Malaysia, United Kingdom, Italy, Switzerland, South Africa, Thailand, India, Singapore, South Korea, Egypt
-
National Cancer Institute (NCI)CompletedRecurrent Breast Carcinoma | Invasive Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v6United States, Puerto Rico
-
Dompé Farmaceutici S.p.APRA Health SciencesCompletedMetastatic Breast CancerUnited States, Spain, Belgium, Italy, France, Czechia, Poland
-
Symbollon PharmaceuticalsUnknownPain | Fibrocystic Disease of Breast | Fibrocystic Changes of Breast | Fibrocystic MastopathyUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedBreast Cancer | Psychosocial Effects of Cancer and Its TreatmentUnited States, Canada
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7United States
-
Eli Lilly and CompanyActive, not recruitingBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Endometrial CancerUnited States, Spain, France, Taiwan, Australia, Belgium, Korea, Republic of, Japan
-
Hoffmann-La RocheTerminatedTriple Negative Breast Cancer | Advanced Ovarian CancerUnited Kingdom, United States, Australia, Denmark, Canada
-
National Cancer Institute (NCI)RecruitingAnatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Hormone Receptor-Positive Breast Carcinoma | HER2-Negative Breast CarcinomaUnited States, Puerto Rico
-
Christian HinrichsNational Cancer Institute (NCI); Iovance Biotherapeutics, Inc.RecruitingCervical Cancer | Breast Cancer | Gastric Cancer | Lung CancerUnited States
-
Calithera Biosciences, IncCompleted
-
Novartis PharmaceuticalsCompletedMetastatic Breast Cancer | HER2/Neu Over-expressing Locally Advanced Breast CancerChina, United States, France, Hungary, Turkey, Japan, Germany, Singapore, Italy, Poland, Spain, United Kingdom, Thailand, Israel, Australia, Belgium, Greece, Argentina, Czech Republic, Mexico, Slovakia
-
Seagen, a wholly owned subsidiary of PfizerMerck Sharp & Dohme LLCActive, not recruitingHER2 Positive Breast CancerUnited States, Netherlands, China, Brazil, Canada, France, Australia, Spain, Belgium, Czechia, Japan, United Kingdom, Taiwan, Finland, Germany, Italy, Poland, Portugal, Austria, Chile, Greece, Switzerland, South Korea
-
AstraZenecaRecruiting
-
Hoffmann-La RocheCompletedBreast CancerIsrael, Italy, Poland, Spain, China, Hong Kong, Australia, Canada, Sweden, Switzerland, United States, South Africa, United Kingdom, Germany, Portugal, Taiwan, Japan, Russian Federation, Singapore, France, Netherlands, Belgium, Austria and more
-
Merck Sharp & Dohme LLCRecruitingTriple-Negative Breast CancerUnited States, Israel, Australia, Malaysia, Spain, Norway, Argentina, Belgium, Germany, Portugal, Finland, Hong Kong, Italy, Canada, Czechia, Switzerland, France, Ireland, United Kingdom, Singapore, Japan, Austria, Brazil, Greece, Mexico, Polan... and more
-
Calithera Biosciences, IncCompletedBreast NeoplasmsUnited States, Spain
-
National Cancer Institute (NCI)CompletedCixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast CancerRecurrent Breast Carcinoma | Male Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7United States
-
Canadian Cancer Trials GroupAlliance for Clinical Trials in Oncology; NRG Oncology; Eastern Cooperative Oncology... and other collaboratorsRecruitingBreast CancerUnited States, Canada
-
National Cancer Institute (NCI)NRG OncologyTerminatedUnresectable Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7 | Metastatic Breast Adenocarcinoma | Metastatic HER2-Positive Breast Carcinoma | Recurrent Breast Adenocarcinoma | Recurrent HER2-Positive Breast Carcinoma | Unresectable HER2-Positive Breast CarcinomaUnited States, Canada
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedBreast CancerUnited States, Canada
-
Hoffmann-La RocheCompletedTriple-Negative Breast CancerFrance, Canada, Israel, Italy, Argentina, Brazil, China, Croatia, Germany, Greece, Slovakia, Turkey, Saudi Arabia, Japan, India, Spain, United States, Czechia, Romania, United Kingdom, Morocco, South Africa, Vietnam, Russian Federation
-
National Cancer Institute (NCI)CompletedRecurrent Breast Carcinoma | Metastatic Triple-Negative Breast Carcinoma | Metastatic Malignant Neoplasm in the Brain | Stage IV Breast Cancer AJCC v6 and v7 | Metastatic Breast Carcinoma | Metastatic BRCA Hereditary Breast CarcinomaUnited States, Puerto Rico
-
NCIC Clinical Trials GroupCompletedBreast Cancer | OsteoporosisUnited States, Canada
-
Numab Therapeutics AGTerminatedColorectal Cancer | Fallopian Tube Cancer | Triple Negative Breast Cancer | Advanced Solid Tumor | Non-small Cell Lung Cancer | Peritoneal Carcinoma | Head and Neck Squamous Cell Carcinoma | Ovarian Carcinoma | Squamous Cell CarcinomaUnited States, Taiwan, Spain
-
AstraZenecaActive, not recruitingBreast CancerBelgium, Spain, Italy, Brazil, Czechia, United States, Chile, Slovakia, Hungary, India, Ukraine, Poland, Colombia, Malta, Mexico, Venezuela, Russia
-
AstraZenecaCompletedBreast CancerUnited States, Brazil, Czech Republic, France, Hungary, Japan, Belgium, Canada, Netherlands, Italy